Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
Authors
Keywords
-
Journal
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-16
DOI
10.1007/s12016-020-08794-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The response to treatment in chronic spontaneous urticaria depends on how it is measured
- (2019) Karsten Weller et al. Journal of Allergy and Clinical Immunology-In Practice
- The Real-Life Effectiveness and Safety of Omalizumab Updosing in Patients With Chronic Spontaneous Urticaria
- (2019) Andac Salman et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta‐analysis
- (2019) Julia Fricke et al. ALLERGY
- Long-term omalizumab outcomes in chronic idiopathic urticaria: a real-world study
- (2019) Abhishek Kavati et al. ALLERGY AND ASTHMA PROCEEDINGS
- Urticaria and angioedema
- (2019) Canting Guo et al. ALLERGY AND ASTHMA PROCEEDINGS
- High-dose omalizumab use in patients with chronic spontaneous urticaria
- (2019) Mehran Alizadeh Aghdam et al. Journal of Allergy and Clinical Immunology-In Practice
- Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE-CSU
- (2018) G. Sussman et al. ALLERGY
- The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
- (2018) T. Zuberbier et al. ALLERGY
- Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria
- (2018) Allen P. Kaplan ALLERGY AND ASTHMA PROCEEDINGS
- Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria
- (2018) L. Curto-Barredo et al. BRITISH JOURNAL OF DERMATOLOGY
- Update on Omalizumab for Urticaria: What’s New in the Literature from Mechanisms to Clinic
- (2018) Désirée E. S. Larenas-Linnemann et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of ‘real-world’ evidence
- (2018) Jonathan A. Bernstein et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The role and relevance of mast cells in urticaria
- (2018) Martin K. Church et al. IMMUNOLOGICAL REVIEWS
- Immunoglobulin E-Mediated Autoimmunity
- (2018) Marcus Maurer et al. Frontiers in Immunology
- Two-week intervals during omalizumab treatment may provide better symptom control in selected patients with chronic urticaria
- (2018) Murat Türk et al. Journal of Allergy and Clinical Immunology-In Practice
- Omalizumab Updosing for Better Disease Control in Chronic Spontaneous Urticaria Patients
- (2018) Emek Kocatürk et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Therapeutic strategy according to the differing patient response profiles to omalizumab in chronic spontaneous urticaria
- (2018) AM Giménez Arnau et al. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
- Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria
- (2018) Michael D. Tharp et al. JAMA Dermatology
- Chronic Spontaneous Urticaria; Centres' of Excellence
- (2017) Carly Barron et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Autoimmune chronic spontaneous urticaria: What we know and what we do not know
- (2017) Pavel Kolkhir et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Chronic urticaria in the real-life clinical practice setting in Sweden, Norway and Denmark: baseline results from the non-interventional multicentre AWARE study
- (2017) S.F. Thomsen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin
- (2017) Martin Metz et al. Theranostics
- The Comparative Safety of Multiple Alternative Agents in Refractory Chronic Urticaria Patients
- (2017) Sharon Seth et al. Journal of Allergy and Clinical Immunology-In Practice
- Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients
- (2017) Zahava Vadasz et al. Journal of Allergy and Clinical Immunology-In Practice
- EAACI/ESCD Skin Allergy Meeting 2017 (SAM 2017)
- (2017) Clinical and Translational Allergy
- Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials
- (2016) Zuo-Tao Zhao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab for Difficult-to-Treat Dermatological Conditions: Clinical and Immunological Features from a Retrospective Real-Life Experience
- (2015) Ciro Romano et al. CLINICAL DRUG INVESTIGATION
- Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H 1 Antihistamines: A Randomized, Placebo-Controlled Study
- (2015) Sarbjit S. Saini et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Real-life experiences with omalizumab for the treatment of chronic urticaria
- (2014) Gordon Sussman et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Letter to the Editor Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases
- (2014) Irene Fiorino et al. Postepy Dermatologii i Alergologii
- Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice
- (2013) Moises Labrador-Horrillo et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
- (2013) Allen Kaplan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- An algorithm for treating chronic urticaria with omalizumab: Dose interval should be individualized
- (2013) Pınar Uysal et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis
- (2013) Martin Metz et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
- (2013) Marcus Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria
- (2011) Sarbjit Saini et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase
- (2011) Marcus Maurer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1
- (2010) M. Maurer et al. ALLERGY
- Safety and tolerability of omalizumab in children with allergic (IgE-mediated) asthma
- (2010) Henry Milgrom et al. CURRENT MEDICAL RESEARCH AND OPINION
- EAACI/GA²LEN/EDF/WAO guideline: management of urticaria
- (2009) T. Zuberbier et al. ALLERGY
- Effect of Anti-IgE (Omalizumab) in Chronic Idiopathic Urticaria (CIU) Patients
- (2008) L GOBER et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation